Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma

Early diagnosis and treatment in pancreatic ductal adenocarcinoma (PDAC) is still a challenge worldwide. The poor survival of PDAC patients mainly due to early metastasis when first diagnosed and lack of prognostic biomarker. Ribosomal protein L15 (RPL15), an RNA-binding protein, is a component of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Ting-Ting, Fu, Xue-Liang, Li, Jiao, Bian, Ying-Nan, Liu, De-Jun, Hua, Rong, Ren, Lin-Lin, Li, Cheng-Tao, Sun, Yong-Wei, Chen, Hao-Yan, Fang, Jing-Yuan, Hong, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper: Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741913/
https://www.ncbi.nlm.nih.gov/pubmed/26498693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741913/
https://www.ncbi.nlm.nih.gov/pubmed/26498693

Ejemplares similares